NanoViricides Inc. (NNVC)

[arvitar]

Your copy of NNVC's chart from FIVE years ago, shows that THREE candidates were partway through IND enabling studies, with the cream having completed IND and about to enter Phase-1 studies, and FOUR drugs about to enter IND enabling studies (at that time).

Your copy of the chart, however, has the bottom cut off that shows TWO additional candidates that were also about to enter IND enabling studies, for a total of SIX candidates about to enter IND studies (in 2015 or 2016)

Since none of it has ever been remotely close to being true, this is a clear example of NNVC's ongoing pattern of willfully misleading the investing public: